MedPath
HSA Approval

ZOLICHEK EYE DROPS SOLUTION 2%

SIN14985P

ZOLICHEK EYE DROPS SOLUTION 2%

ZOLICHEK EYE DROPS SOLUTION 2%

April 8, 2016

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01EC03

dorzolamide

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Indoco Remedies Limited

Active Ingredients

Dorzolamide Hydrochloride 22.3 mg/ml eqv. Dorzolamide

20mg/ml

Dorzolamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZOLICHEK EYE DROPS SOLUTION 2% - HSA Approval | MedPath